Skip to main content
. Author manuscript; available in PMC: 2013 Apr 12.
Published in final edited form as: Int Urogynecol J Pelvic Floor Dysfunct. 2009 Feb 20;20(5):581–589. doi: 10.1007/s00192-009-0838-5

Table 1.

Baseline Prevalence Any Urinary Incontinence & Severe Urinary Incontinence & Deaths from Baseline to Follow-up

5th 6th 7th 8th 9th

White
Any UI 18.29%(691/3777) 18.47%(460/2490) 23.19%(717/3092) 28.40%(324/1141) 34.66%(61/176)
Severe UI 4.26%(161/3777) 5.90%(147/2490) 8.21%(254/3092) 12.36%(141/1141) 19.32%(34/176)
% died 2.54% ( 96/3777) 5.42%(135/2490) 12.10%(374/3092) 31.81%(363/1141) 52.27%(92/176)

African American
Any UI 10.21%(92/901) 13.94% (76/545) 13.70%(73/533) 23.6%(50/214) 17.86% (5/28)
Severe UI 2.22%(20/901) 5.69% (31/545) 4.69% (25/533) 8.8% (19/214) 10.71%(3/28)
% died 3.55% (32/901) 8.81% (48/545) 18.57%(99/533) 29.44%(63/214) 53.57%(15/28)

Hispanic
Any UI 11.36%(56/493) 10.78%(19/269) 17.90%(41/229) 19.12%(13/68) 27.27%(3/11)
Severe UI 2.23% (11/493) 3.35% (9/269) 5.68%(13/229) 11.76%( 8/68) 18.18%(2/11)
% died 3.04%(15/493) 7.06%(19/269) 13.97%(32/229) 11.76%( 8/68) 63.64%(7/11)

Other
Any UI 9.84%(12/122) 19.44%(14/72) 13.64%( 9/66) 38.89%(7/18) 0%(0/1)
Severe UI 3.28% (4/122) 5.56% (4/72) 3.03% (2/66) 16.67% (3/18) 0%(0/1)
% died 1.64%( 2/122) 9.72%( 7/72) 16.67%(11/66) 38.89%(7/18) 0%(0/1)

Overall
Any UI 16.08%(851/5293) 17.15%(579/3376) 21.43%(840/3920) 27.34%(394/1441) 31.94%( 69/216)
Severe UI 3.70%(196/5293) 5.66% (191/3376) 7.50%(294/3920) 11.87%(171/1441) 18.06%( 39/216)
% died 2.74%(145/5293) 6.19%(209/3376) 13.16%(516/3920) 30.60%(441/1441) 52.78%(114/216)